Insight
New Nomogram Predicts
Felipe Couñago/X

Felipe Couñago: Review on GnRH Antagonists in Prostate Cancer in Arch Esp Urol

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X:

“Just out!
Review on GnRH antagonists in prostate cancer in Arch Esp Urol.

  •  No flare
  •  Fast T suppression
  •  Possible CV benefit

But evidence still evolving.

Thanks to all co-authors!”

Title: GnRH Antagonists: Current Evidence and Role in Prostate Cancer

Authors: Antonio Lazo, Manuel Blanco, Abrahams Ocanto, Victor Duque-Santana, Rocio Del Castillo, Marta Barrado, Juan Zafra, Fernando López-Campos, Felipe Couñago

Read the Full Article.

Felipe Couñago

More posts featuring Felipe Couñago.

Abrahams Ocanto Antonio Lazo cancer Felipe Couñago Fernando López Campos Juan Zafra Manuel Blanco Marta Barrado OncoDaily Oncology prostate cancer Rocio Del Castillo Victor Duque-Santana